# Nurix Therapeutics, Inc. (NRIX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NRIX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 15.30M | $ -176.71M | $ -171.47M | $ 58.14M | $ 402.63M |
| 2025 | $ 85.99M | $ -270.78M | $ -269.77M | $ 55.73M | $ 538.75M |
| 2024 | $ 57.34M | $ -203.46M | $ -191.15M | $ 28.30M | $ 526.99M |
| 2023 | $ 83.24M | $ -155.64M | $ -97.06M | $ 30.61M | $ 200.49M |
| 2022 | $ 43.15M | $ -201.48M | $ -192.20M | $ 11.96M | $ 303.70M |
| 2021 | $ 35.36M | $ -139.30M | $ -107.01M | $ 13.04M | $ 342.30M |
| 2020 | $ 22.70M | $ -55.09M | $ -5.90M | $ 0 | $ 290.27M |
| 2019 | $ 40.16M | $ -28.01M | $ -1.36M | $ 0 | $ -57.71M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.14 |
| Liabilities / Eq | 0.33 |
| Current Ratio | 6.34 |

## Other views

- [Metrics](https://sponda.capital/en/NRIX.md)
- [Charts](https://sponda.capital/en/NRIX/charts.md)
- [Compare](https://sponda.capital/en/NRIX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.